At the end of Q1 2026, 25 institutions reported holding Serina Therapeutics Inc. (SER) in their 13F filings, up 3 from Q4 2025. 7 opened new positions and 5 sold out. The largest holders were Sio Capital Management, LLC ($1.9M), Vanguard Capital Management LLC ($309K) and Waverly Advisors, LLC ($131K).
Company
Serina Therapeutics Inc.
CUSIP
81751A108
Latest filing quarter
Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
Institutions
Total Value
New Positions
7
$2.1M
Exits
5
$190K
All 13F filers, Q4 2025 → Q1 2026: 1,143,159 shares bought and 99,777 shares sold, net +1,043,382 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.